Compare Lithium Americas Corp (LAC) vs ResMed Inc. (RMD) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Lithium Americas Corp vs ResMed Inc. — how do they compare? Lithium Americas Corp trades at $3.3 (market cap $1.18B), while ResMed Inc. trades at $221.22 (market cap $32.61B). The key difference: ResMed Inc. is far larger — about 27.6× Lithium Americas Corp's market cap, and ResMed Inc. pays a 1.17% dividend while Lithium Americas Corp pays none. Which is the better fit depends on your goals.
| LAC | RMD | |
|---|---|---|
Market Cap | $1.18B | $32.61B |
Sector | Basic Materials | Health |
52-Week High | $10.05 | $293.73 |
52-Week Low | $2.71 | $182.82 |
Enterprise Value | $1.29B | $31.97B |
Dividend Yield | — | 1.17% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Lithium Americas Corp
Lithium Americas is a resource company focused on developing the Thacker Pass project in Nevada, the largest known lithium resource in the US. It aims to become a major supplier for the electric vehicle battery market.
Read more on LAC →About ResMed Inc.
ResMed is one of the largest respiratory care device companies globally, primarily developing and supplying flow generators, masks and accessories for the treatment of sleep apnea. Increasing diagnosis of sleep apnea combined with ageing populations and increasing prevalence of obesity is resulting in a structurally growing market. The company earns roughly two thirds of its revenue in the Americas and the balance across other regions dominated by Europe, Japan and Australia. Recent developments and acquisitions have focused on digital health as ResMed is aiming to differentiate itself through the provision of clinical data for use by the patient, medical care advisor and payer in the out-of-hospital setting.
Read more on RMD →
